The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease

Area of Science:

• Neuroscience
• Genetics
• Radiology

Background:

• Huntington's disease (HD) is a progressive neurodegenerative disorder.
• Early detection of HD's cognitive impact is crucial for management.
• Striatal dopamine receptors are implicated in cognitive functions.

Purpose of the Study:

• To investigate cognitive performance and striatal dopamine receptor binding in individuals at risk for Huntington's disease.
• To determine if cognitive deficits and receptor changes precede clinical symptoms.

Main Methods:

• Positron Emission Tomography (PET) with [11C]SCH23390 and [11C]raclopride to measure dopamine D1 and D2 receptor binding.
• Neuropsychological testing assessing verbal fluency, memory, attention, and planning.
• Comparison between symptomatic HD patients, asymptomatic carriers, and healthy controls.

Main Results:

• Asymptomatic and symptomatic HD mutation carriers showed cognitive impairments in planning, sequencing, and verbal fluency.
• Cognitive performance and dopamine receptor levels (especially D2) correlated with disease progression markers.
• Asymptomatic individuals closer to their estimated age of onset exhibited lower receptor levels and poorer cognitive function.

Conclusions:

• Cognitive deficits associated with striatal dysfunction are detectable in Huntington's disease mutation carriers before overt motor symptoms.
• Striatal dopamine D1 and D2 receptor binding is linked to cognitive performance in HD.
• These findings highlight the potential for early identification of neurobiological changes in Huntington's disease.